PVLA

Palvella Therapeutics, Inc. - Common Stock (PVLA)

About Palvella Therapeutics, Inc. - Common Stock (PVLA)

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Details

Daily high

$155.11

Daily low

$151.31

Price at open

$152.40

52 Week High

$161.38

52 Week Low

$56.54

Market cap

2.2B

Dividend yield

Volume

123,590

Avg. volume

222,026

P/E ratio

-31.14

Palvella Therapeutics, Inc. - Common Stock News